1,293
Participants
Start Date
October 27, 2014
Primary Completion Date
July 14, 2016
Study Completion Date
July 14, 2016
DS-5565
DS-5565 15 mg tablet for oral administration
Pregabalin
Pregabalin 150 mg capsule for oral administration
Placebo tablet
Placebo tablet (matching DS-5565) for oral administration
Placebo capsule
Placebo capsule (matching pregabalin) for oral administration
New York
Hartsdale
Williamsville
Allentown
Philadelphia
Wheaton
High Point
Greensboro
Summerville
Greenville
Savannah
Port Orange
Boynton Beach
St. Petersburg
Biloxi
Toledo
Elwood
Southfield
Dakota Dunes
Chicago
St Louis
Newton
Omaha
Carrollton
Allen
Richardson
Dallas
Houston
Austin
Denver
Colorado Springs
Bountiful
Las Vegas
Beverly Hills
Torrance
Los Alamitos
Sherman Oaks
San Diego
Tustin
Roseville
Glendale
Phoenix
Anaheim
Newport Beach
Oakland
Rancho Mirage
Cromwell
Danbury
Bradenton
Brooksville
Coral Springs
Gainesville
Jacksonville
Lakeland
Miami
Ocala
Orlando
Royal Palm Beach
Sanford
Indianapolis
Wichita
Fall River
Methuen
New Bedford
Hattiesburg
Kansas City
Springfield
Princeton
West Long Branch
Valley Stream
Charlotte
Durham
Raleigh
Winston-Salem
Cincinnati
Middleburg Heights
Oklahoma City
Medford
Mechanicsburg
Anderson
Fountain Inn
Tullahoma
DeSoto
Lubbock
Mesquite
Plano
Sugar Land
Seattle
Morgantown
Burlington
Edmonton
Kentville
Penticton
Sherbrooke
Vancouver
Winnipeg
Choceň
Prague
Rychnov nad Kněžnou
Říčany
Aalborg
Odense
Hyvinkää
Kokkola
Amiens
Cubray
Élancourt
Grenoble
Paris
Saint-Etienne
Toulouse
Bad Doberan
Berlin
Böhlen
Chemnitz
Cologne
Cottbus
Dresden
Eichstätt
Essen
Fellbach
Frankfurt
Hamburg
Jena
Leipzig
Mainz
Marburg
Mönchengladbach
Munich
Rodgau
Stadtroda
Wallerfing
Weinheim
Westerstede
Wiesbaden
Würzburg
Beek
Leiden
Sneek
Ålesund
Hamar
Hønefoss
Kløfta
Lier
Lillehammer
Stavanger
Belgrade
Kragujevac
Niš
Novi Sad
Borås
Mölndal
Stockholm
Boston
Berlin
Stratford
Kitchener
London
Markham
Mississauga
Newmarket
Oshawa
Pointe-Claire
Sarnia
Toronto
Lead Sponsor
Collaborators (1)
Syneos Health
OTHER
Daiichi Sankyo
INDUSTRY